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Pomace olive oil is a byproduct of olive oil extraction that is traditionally produced and 
consumed in Spain. The non-glyceride matter of this oil is a good source of interesting 
minor compounds, like long-chain fatty alcohols, which are present free or as part of 
waxes. In the present study, long-chain fatty alcohols were isolated from the non-
glyceride fraction of pomace olive oil and the composition was identified and quantified. 
The major components of long-chain fatty alcohols were tetracosanol, hexacosanol and 
octacosanol. We investigated the ability of long-chain fatty alcohols from pomace olive 
oil to inhibit the release of different pro-inflammatory mediators in vitro by cells involved 
in inflammatory processes. Long-chain fatty alcohols significantly and dose-
dependently decreased nitric oxide production by RAW 264.7 murine macrophages 
stimulated with lipopolysaccharide. Western-blot analysis showed that nitric oxide
reduction was a consequence of the inhibition of iNOS expression. Long-chain fatty 
alcohols also reduced TNF-α and prostaglandin E2 production, although the potency of 
inhibition for the latter was lower. On the other hand, long-chain fatty alcohols
significantly reduced thromboxane A2 production in rat peritoneal neutrophils stimulated 
with the calcium ionophore A-23187. The reduction of eicosanoid release was related 
to the inhibition of phospholipase A2 enzyme activity by long-chain fatty alcohols, 
reaching an IC50 value of 6.2 μg/ml. These results showed that long-chain fatty alcohols
may have a protective effect on some mediators involved in the inflammatory damage 
development, suggesting its potential value as a putative functional component of 
pomace olive oil.
3INTRODUCTION
Virgin olive oil (VOO), a source of healthy micronutrients, may be regarded as a
functional food due to its important beneficial effects. An increasing number of studies 
are pointing out the important biological effects of some of these micronutrients and 
that the content of oleic acid can not fully explain the impact of VOO on health [1,2]
Minor components of VOO, found in the non-glyceridic fraction, may also explain some
of the healthy effects of the Mediterranean diet [3,4]. Pomace olive oil (POO) is 
obtained from the wastes after the extraction of VOO by mechanical procedures and 
contains components from the leaves, skin and seeds. Despite the glyceridic fraction 
being similar [5], some of the minor components are present in higher concentration in
POO than in VOO [6,7]. Thus, the unsaponifiable fraction of POO contains elevated 
amounts of sterols, tocopherols, waxes and triterpenic acids and alcohols with 
important biological activities. Among these, recent investigations have revealed the 
vasorelaxant, antioxidant and anti-inflammatory properties of erythrodiol and oleanolic 
and maslinic acids [2,8-10].
Another fraction of the minor components of POO that has received insufficient 
attention to date is that of long-chain fatty alcohols (LCFA). These compounds are 
usually found in waxes of common foods and have been isolated from sugarcane,
spinach and beeswax by saponification and solvent extraction. A number of beneficial 
physiological activities have been attributed to LCFA, such as reducing platelet 
aggregation, endothelial damage and cholesterol lowering effects [11,12]. All these 
studies have been carried out using “Policosanol”, a commercialized mixture of LCFA
[13,14], whose major components are octacosanol (C28), triacontanol (C30) and 
hexacosanol (C26). Octacosanol, is in fact known for its antiaggregant effect, as an 
alternative to aspirin for patients suffering from gastric irritation due to its cytoprotective 
effects [15]. Although present in relatively high concentrations, the biological activities 
of LCFA from POO have not been studied yet.
Nitric oxide (NO) has been shown to play a central role in inflammatory and immune 
reaction activities. Macrophages appear to be the main cellular source of NO since
these cells significantly contribute to inducible NO synthetase (iNOS) induction after 
lipopolysacharide (LPS) incubation [16]. NO is also able to enhance the production of 
tumour necrosis factor-α (TNF-α) and IL-1β cytokines, which participate in the 
macrophage-dependent inflammation [17]. Activation of macrophages also leads to 
ciclooxygenase 2 (COX-2) stimulation with consequent prostaglandin E2 (PGE2) 
4overproduction, which plays a key role in the pathogenesis of inflammatory processes
[18]. Another eicosanoid of particular importance is thromboxane A2 (TXA2), which is 
produced by the action of thromboxane synthase on the prostaglandin endoperoxide H-
2 (PGH2) resulting from the enzymatic transformation of arachidonic acid by the COX-
2. TXA2 is a potent inducer of platelet aggregation, vasoconstriction and 
broncchoconstriction, and has been involved in a series of major pathophysiological 
conditions [19].
Arachidonic acid is released from phospholipids by the action of the secretory 
phospholipase A2 (sPLA2), thereby providing the substrate for the biosynthesis of 
proinflammatory eicosanoids. sPLA2 is released in plasma and other biologic fluids of 
patients with systemic inflammatory, autoimmune, and allergic diseases. Different 
isoforms of sPLA2 are expressed and released by several cells types, such as 
neutrophils, basophils, T-cells, monocytes, macrophages, and mast cells where
promotes cytokine and chemokine production. Thus, sPLA2 might play important roles 
in the initiation and amplification of inflammatory reaction [20,21]. Therefore, the 
inhibition of PLA2 could result in down-regulation of the inflammatory response, acting 
at an early step of several inflammatory mediator biosynthesis. 
The aim of our study was to analyze and identify the composition of the LCFA fraction, 
isolated from POO and to examine its ability to inhibit the release of some 
proinflammatory mediators by cells involved in inflammation. With this purpose, we 
investigated the effect of LCFA to inhibit the sPLA2 enzyme activity, in vitro and on NO, 
PGE2 and TNF generation in LPS-stimulated RAW-macrophages, as well as the TXA2




The unsaponifiable fraction of POO was isolated following conventional procedures. In 
brief, POO was saponified with 25 ml of 2 mM KOH in methanol:water (80:20, v/v). 
After heating at 70ºC for 30 min, 50ml of water and 50ml of ethyl ether were added. 
The unsaponifiable fraction was collected by decantation and its components were 
analyzed following the IUPAC method [22]. 1.5 g of the unsaponifiable fraction was 
fractioned on a silica gel column and the LCFA subfraction eluted with a mixture of 
hexane and ethyl ether (85:15, v/v). The same procedure was used to obtain the LCFA 
fraction that was added to the cell culture medium at appropriate concentrations. For 
LCFA analysis by gas chromatography, the isolated LCFA were transformed into 




LCFA were analyzed with a Chrompack (Middelburg, The Netherlands) CP900 gas 
chromatograph equipped with a capillary column SGL-5, of 30 m lenght, 0.25 mm i.d 
and 0.25 µm film thickness of  5% phenyl methylpolysiloxane stationary phase. Carrier 
gas was hydrogen, with a head pressure of 110 KPa and 1:60 split ratio. Injector 
temperature was 280°C and detector temperature 290°C. The oven temperature was 
programmed from 215 °C to 290 °C with a rate of 2°C/minute. The analysis was carried 
out following the method of the Commission Regulation (EC) Nº 1989/2003. Amending 
Regulation (EC) 2568/91 on the characteristics of olive and the relevant method of 
analysis. Total LCFA concentration in POO was calculated as the sum of individual 
LCFA concentrations. 
Reagents
 [5,6,8,11,12,14,15 (n)-3H] PGE2 was from Amersham Biosciences (Madrid, Spain). [9, 
10-3H] Oleic acid was purchased from Du Pont, (Itisa, Madrid, Spain). Mouse TNF-α
and TXB2 ELISA were from BLK Diagnostics (Badalona, Spain). The rest reagents 
were purchased from Sigma Aldrich Chem. (St. Louis, MO, U.S.A.). Stock solutions of 
compounds were prepared in DMSO and later dissolved in ethanol. The final 
concentration of DMSO or ethanol in the culture medium did not significantly influence 
6cell response. The quantities of the compounds are expressed as their final 
concentration in the culture medium.
Assay of sPLA2
Secretory phospholipase A2 was assayed by using a modification of the method of 
Franson [23]. Escherichia coli strain CECT 101 were seeded in medium containing 1% 
tryptone, 0.5% NaCl and 0.6% sodium dihydrogen ortophosphate, pH 5.0 and grown 
for 6 to 8h at 37ºC in the presence of 5Ci Ci/ml 3H/oleic acid (sp. Act. 10 Ci/mmol). 
After centrifugation at 2500 g for 10 min, the cells were washed in buffer (0.7 M tris-
HCl,  10 mM Ca Cl2, 0.1% BSA, pH 8.0) resuspended in saline and autoclaved for 30 to 
45 min. At least 95% of the radioactivity was incorporated into phospholipids. Human 
recombinant synovial enzyme was added to a solution of 100 mM (Tris HCl, 1mM Ca 
Cl2 buffer pH 7.5), and preincubated at 37ºC for 5 min with 2.5 l of test compound 
solution at different doses (1, 5, 10, 50 and 100 µg/ml) or its vehicle in a final volume of 
250 µl. Incubation proceeded for 15 min in the presence of 10 µl of autoclaved oleate-
membranes and was terminated by addition of 100 µl ice-cold solution of 0.25% BSA in 
saline to a final concentration of 0.07% w/v. After centrifugation at 2500 g for 10 min at 
4ºC, the radioactivity in the supernatants was determined by liquid scintillation 
counting. The inhibitory effect was measured in relation to control enzyme activity 
(radioactivity in cpm.) in tubes containing enzyme.
Cell viability
The mitochondrial dependent reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) to formazan was used to asses the possible 
cytotoxic effect on the mouse macrophage cell line RAW 264.7.
Culture of murine macrophage RAW 264.7 cell line
The mouse macrophage cell line RAW 264.7 (Cell Collection, Department of Animal 
Cell Culture, C.S.I.C., Madrid, Spain) was maintained in Dubelcco’s Modified Eagle’s 
Medium (DMEM) supplemented with L-glutamine 2 mM, 100 U/ml penicillin, 100 µg/ml
streptomycin and 10% heat inactivated foetal bovine serum (FBS). Macrophages were 
removed from the tissue culture flask using a cell scraper and centrifuged at 800 g for 
10 min. Cells were resuspended at a concentration of 1x106 cell/ml in a total volume of 
200 µl and culture in 96 well culture plate. 
7Nitrite, PGE2 and TNF- production in Raw 264.7 macrophages
RAW 264.7 macrophages (1x106cell/ml) were co-incubated with 10 g/ml of 
Escherichia coli (serotype 0111:B4) LPS at 37ºC for 24h in the presence of LCFA
fractions at different doses (25, 50 or 100 µg/ml) or vehicle. Nitrite (as index of NO 
generation) was determined in culture supernatants by a flurometric method [24]. PGE2
and TNF- levels production were quantified by sandwich immunoassay [25,26].
Western blot analysis of iNOS expression
To induce iNOS expression, RAW 264.7 cells (2x106 cell/ml) were incubated with LPS 
(10 g/ml) in 6-well culture plate in the presence of the highest fraction concentrations 
(100 g/ml). Dexamethasone at 10 µM was used as standard reference of iNOS gene 
expression inhibition. After 18 h stimulation, medium was removed and cells were 
washed twice with PBS 25 mM, then cells were lysed with lysis buffer (1% triton X-100, 
1% deoxycholic acid, 20mM NaCl, and 25mM Tris, pH 7.4). Following centrifugation 
(10000 g, 15 min), protein was determined in supernatants, by the DC Bio-Rad protein
assay reagent (Bio-Rad, Hercules, Ca., USA). Equal amounts of protein (25 µg) were 
loaded on 12% SDS-PAGE and transferred onto pure nitrocellulose membranes for 90 
min at 125 mA. Membranes were blocked in PBS-Tween 20 containing 3w/w unfatted 
milk. Membranes were incubated with specific iNOS polyclonal antibody (1/1500 
dilution; Santa Cruz, California); blots were washed and incubated with peroxidase-
conjugated goat anti-rabbit Ig G (1/3500 dilution; DAKO, Denmark). The 
inmunoreactive bands were visualized using enhanced chemiluminiscence system 
(ECL; Amersham Biosciences, Madrid, Spain).
TXB2 release by A-23187 stimulated rat neutrophils
Leukocytes containing approximately 85% polymorphonuclear leukocytes (PMNs) and 
15 % mononuclear cells were prepared [25] from male Wistar rats and resuspended in 
complete HBSS at 0.5  106 cells/mL containing 1.26 mM Ca2+ and 0.9 mM Mg2+. Cell 
viability based on trypan blue exclusion was greater than 95%. Triplicate aliquots of 0.5 
mL leukocytes were preincubated at 37C for 10 min with 2 L dimethylsulphoxide 
(DMSO) containing LCFA.  After this, 5L of calcium ionophore A23187 was added in
DMSO to give a final concentration of 1 M for a further 10 min of incubation. The cells 
were pelleted by centrifugation at 2500 g for 10 min at 4C, and the supernatants were 
8decanted and frozen. For the TXB2 assay aliquots the supernatant were subjected to a 
commercially available sandwich immunoassay kit.
Data analysis
The results are presented as mean ± SEM; inhibitory concentration 50% (IC50) values 
were calculated from at least three concentrations. Statistically significant differences 
were evaluated by analysis of variance (ANOVA) followed by Dunnet’s t-test for 
multiple comparisons.
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Analysis of the sample composition
LCFA were isolated from the POO unsaponificable fraction and its constituents were 
identified by gas chromatography (Figure 1) as a mixture of very-long-chain aliphatic 
alcohols, whose main components were: docosanol (C22) (7.5%), tetracosanol (C24) 
(30.3%), hexacosanol (37.3%) and octacosanol (15.3%) (Table 1). Additionally, small 
concentrations of the odd series, n=23, 25, 27 and terpenic alcohols as phytol 
(C20H40O) or geranylgeraniol (C20H34O) were also detected. Total LCFA 
concentration in POO was 1853 mg/kg, calculated as the sum of individual LCFA 
concentrations.
Inhibition of sPLA2 activity
As shown in Figure 2, the LCFA fraction was revealed as an effective inhibitor of 
human recombinant synovial phospholipase A2 activity at all assayed doses (1-100 
g/mL), reaching an IC50 value of 6,2 µg/ml. The percentage of inhibition ranged from 
about 6.5% at 1 g/mL to 68% at 100 g/mL.
Effect of LCFA on cell viability 
LCFA did not induced toxicity in the macrophage cell line when assessed by 
mitochondrial reduction of MTT after 24 h treatment. Viability of cells treated with LCFA 
was 87± 0.8%, 95 ± 0.8% and 99 ± 0.5% at LCFA concentrations 100 μg/ml, 50 μg/ml
and 25 μg/ml, respectively.
Nitrite, PGE2 and TNF production by LPS-stimulated RAW 264.7 macrophages
The effect of LCFA on the release of inflammatory mediators by LPS-stimulated RAW 
264.7 macrophages is depicted in Figure 3. Co-incubation with LCFA significantly 
reduced nitrite production, in a dose dependent manner, with an IC50 value of 53.4 
µg/ml (Figure 3A). The highest inhibition was achieved at 100 g/mL (88%) but even at 
the lowest concentration assayed (1 g/mL), an inhibition of 20% was observed.
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Likewise, PGE2 generation was also reduced by LCFA at all doses assayed although 
the percentage of inhibition was lower than that of nitrite (Figure 3B). The highest 
inhibition was found at 100 g/mL and was quantified as 38% of total PGE2 production.
In contrast, LCFA were able to significantly inhibit TNF-α generation only at the highest 
dose assayed (100 μg/ml) (Figure 3C). Nevertheless, the percentage of inhibition was 
very high (83%).
iNOS expression
Western blot assay in LPS-stimulated RAW 264.7 macrophages was performed to 
assess possible effects on iNOS enzyme gene expression. Figure 4 shows that LCFA 
at 100 μg/ml caused a complete inhibition of the LPS-induced iNOS expression 
(100%). This effect was similar to dexamethasone, the reference compound. 
Effect of LCFA on the TXB2 release by rat neutrophils
LCFA inhibited TXA2 generation (measured as TXB2) release by rat neutrophils 
stimulated with calcium ionophore A.23187 at all assayed doses (Figure 5). The 
concentration-dependent study showed an IC50 value of 56.17 µg/ml.
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DISCUSSION
POO is a byproduct of VOO extraction, obtained from the wastes originated 
after the first pressing of the olive fruit. The new improved procedure for POO
extraction by centrifugation, instead of using organic solvents, allows the presence of
higher concentrations of interesting minor components from the olive fruit and leaves.
The present study demonstrates that a fraction isolated from POO, constituted by 
LCFA, is able to reduce the generation of mediators involved in the inflammatory 
response in different experimental models.
Chemical and nutritional studies have shown that mixtures of long-chain 
primary alcohols extracted from waxy materials from different sources, such as 
beeswax, rice bran, wheat germ, sugar cane and grain sorghum, are able to exert 
several beneficial physiological effects. The main linear aliphatic alcohols present in 
olive oil are tetracosanol (C24), hexacosanol (C26), octacosanol (C28) and docosanol 
(C22) and are found in significantly larger amounts in POO than in VOO [27]. In 
agreement with these authors, the main fatty alcohol present in the LCFA fraction 
isolated from POO was hexacosanol (37.3%), followed by tetracosanol (30.3%), 
octacoasnol (15.3%) and docosanol (7.5%), accounting for 90% of total LCFA. This 
composition is slightly different of that of policosanol, a commercial mixture of very-
long-chain alcohols composed mainly of octacosanol (~60%), triacontanol (~13%) and 
hexacosanol (~6%) [12]. A number of clinical studies have documented the ability of 
policosanol to reduce serum cholesterol, [11,14,28] although a very recent clinical 
study was unable to find a significant cholesterol-lowering effect [29]. Other studies had 
demonstrated that this alcohol mixture, administrated orally to rabbits was effective in 
preventing the development of atherosclerosis lesions in the aorta [11]. Atherosclerosis 
is considered a low-grade chronic inflammatory disease as it shows many of the 
hallmarks of an inflammatory disease [30]. Many studies have shown that the process 
of atherogenesis in part starts with the interaction between activated leucocytes and 
activated endothelium [31]. Molecules including cytokines, chemokines, growth factors 
and prostanoids have an important role in vascular homeostasis. 
Macrophages play a key role in the development of the atherosclerotic lesion
[32]. The onset of atherosclerosis involves attraction of monocytes to the vessel wall at 
local sites of endothelial dysfunction. The monocytes subsequently migrate through the 
endothelium and differentiate into macrophages. Atherogenesis is accompanied by the 
local production and secretion of inflammatory mediators, for which the macrophage is 
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a major source. Activated macrophages secrete eicosanoids, nitric oxide, and 
proinflammatory cytokines, which play a key role in the pathogenesis of the
inflammatory disease. Thus, the expression and activity of iNOS and COX-2 greatly 
modulate the synthesis of NO and prostaglandins and hence, the inflammatory 
response. Shinbori et al., [33] have recently reported that haxacosanol (C26) can 
improve diabetes-induced hypercontraction by down-regulation of iNOS expression. 
Our study demonstrates that LCFA are able to inhibit nitrite production from LPS-
stimulated RAW 264.7 macrophage culture without indication of cytotoxicity. The 
reduction of nitrite concentrations in supernatants of cells co-incubated with LPS and 
the fraction tested can be either due to an interference with the enzyme induction by 
LPS or due to a direct action of LCFA on iNOS activity. Western blot analysis showed 
that the LCFA fraction is highly involved in iNOS protein expression. Thus, this fraction 
may selectively inhibit the enhanced iNOS expression and might control high 
production of NO during inflammatory or immune conditions. Statins are potent 
hypoholesterolemic drugs, which have been shown to suppress iNOS gene expression 
in RAW264.7 macrophages [34]. Like statins, LCFA are also hydroxymethyl-glutaryl-
coenzyme A (HMG-CoA) reductase inhibitors and, in fact, the cholesterol-lowering 
effect of policosanol has been attributed to this activity [12]. For this reason, it has been 
hypothesized that LCFA might mimic the effect of statins on iNOS expression [35]. 
Should this hypothesis turns out to be correct, LCFA might modulate nitric oxide 
release by acting on iNOS transcription, probably by inactivating the nuclear 
transcription factor NFB, just as statins do [36]. 
LCFA also reduced TNF production by LPS-stimulated RAW 264.7 
macrophages, but only at the highest concentration tested (100 g/mL). Hexacosanol 
has also been shown to decrease cytokine concentrations in the kidney of 
streptozotocin-induced diabetic rats [37]. In fact, Muller et al., [38] reported that 
synthetic LCFA, bearing an -tocopherol moiety, reduce TNF secretion by LPS-
activated microglia. According to these authors, this effect would be also mediated by 
NFB activation. This transcription factor is also involved in COX-2 transcription [39], 
the enzyme responsible for the synthesis of PGE2. Our results show that LCFA also 
reduce PGE2 release in a dose-dependent manner, although the effect was not so 
potent. Therefore, our results overall suggest that the effect of the LCFA fraction from 
POO might be mediated by the inactivation of NFB. 
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As well as promoting cytokine and chomokine production by macrophages, 
sPLA2 releases arachidonic acid from phospholipids, providing the substrate for the 
biosynthesis of PGE2 by COX-2. Therefore, sPLA2 plays an important 
pathophysiological role in the initiation and amplification of the inflammatory reaction
[20]. LCFA isolated from POO revealed as potent inhibitors (IC50: 6.2 μg/ml) of human 
recombinant sPLA2 in vitro. IC50, or the half maximal inhibitory concentration, 
represents the concentration of particular molecule that is required to inhibit some 
biological processes by 50% and is used as a measure of this molecule potency; 
therefore the smaller IC50 the less molecule amount needed to exert a biological 
process. In our study only 6.2 μg/ml of LCFA was needed to inhibit PLA2 production by 
50%, which shows the high potency of LCFA. The reduction of de PLA2 enzymatic 
activity was even significant at the lowest dose assayed (1 g/mL). These promising 
results, in the experimental model used, suggest that LCFA fraction could have a 
possible role as functional component of POO. 
Neutrophils migrate to the site of inflammation and, upon activation by different 
stimuli, generate large amounts of pro-inflammatory mediators including TXA2, an
arachidonic-derived bioactive metabolite with particular importance in the pathogenesis 
of inflammatory and thromboembolic diseases. TXA2 is produced by the action of 
thromboxane synthase on the prostaglandin endoperoxide H2 (PGH2), which results 
from the enzymatic transformation of arachidonic acid by COX. It is a potent inducer of 
platelet aggregation, vasoconstriction and bronchoconstriction, and has been involved 
in a series of major pathophysiological conditions [40]. LCFA significantly reduced
TXA2 (measured as TXB2) in a dose-dependent manner after overproduction by
calcium ionophore A23187-stimulated neutrophils. These results agree with other 
others experimental studies carried out with policosanol. This mixture of LCFA has 
been reported to lower TXA2 serum levels in both animals and humans, which was 
accompanied to arachidonic acid-induced platelet aggregation [14,41]
A number of very recent investigations are pointing out that POO or some its 
components may have potent activities against the development of atherosclerosis 
[2,8,9,42]. Our study demonstrated that the LCFA fraction, isolated from POO, can 
reduce the release of different inflammatory mediators (eicosanoids, cytokines and NO)
by interfering in different stages of their metabolic pathways, like iNOS expression or 
PLA2 activity. Thus, the present results suggest that the LCFA fraction may confer a 
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FIGURE LEGENDS
Figure 1. Gas chromatogram of the LCFA fraction from pomace olive oil (POO).
Retention times and carbon numbers are shown on the peaks. C21OH: monocosanol; 
C22OH: docosanol; C23OH: tricosanol; C24OH: tetracosanol; C25OH: pentacosanol; 
C26OH: hexacosanol; C27OH: heptacosanol; C28OH: monocosanol; C29OH: 
nonacosanol; C30OH: triacontanol. 
Figure 2. Effect of LCFA on human recombinat synovial phospholipase A2 activity. 
Results show means  SEM from 3 different experiments (*p<0.05 **p<0.01 versus 
control). Control: total PLA2 enzyme activity. The LCFA fraction was extracted from 
POO as described in the Methods and Materials section.
Figure 3. Effect of LCFA on the production of nitrite (A), PGE2 (B) and TNF- (C) by
LPS-stimulated RAW-264.7 murine macrophages. Cells (1x106 cells/ml) were 
incubated with LPS (10 g/ml) in the presence of different LCFA concentrations. Each 
value represents the mean± S.E.M. for more than two triplicate experiments. **:p<0.01;  
***:p<0.001 versus LPS control group. The LCFA fraction was extracted from POO as 
described in the Methods and Materials section.
Figure 4. Effect of LCFA on iNOS expression by RAW 264.7 cells. The figure is 
representative of three similar experiments. B:unstimulated  cells; LPS: LPS-stimulated 
cells; Dex: LPS stimulated cells treated with dexamethasone at 10M; LCFA: LPS 
stimulated cells treated with LCFA at 100 g/ml. Calculation of iNOS expression after 
LCFA or dexamethasone treatments relative to LPS-stimulated cells was carried out by 
means of densitometric analysis (O.D.).The LCFA fraction was extracted from POO as 
described in the Methods and Materials section.
Figure 5. Effect of LCFA on TXB2 production by peritoneal rat neuthrophils (2.5x10
6
cell/ml) stimulated with the calcium ionophore A23187. Each value represents the 
mean±S.E.M. for three triplicate experiments. *:p<0.05; ***:p<0.001 versus calcium 
ionophore A23187 control group. The LCFA fraction was extracted from POO as 
described in the Methods and Materials section.
Table 1. Composition of the LCFA fraction from pomace olive oil (POO) analyzed by 
gas-chromatography. 
  
                                                                                               
Composition (%)                   NAME
C20H40O 1.9                                      phytol
C20H34O 2.0                                          geranylgeraniol
C22OH 7.5                                      docosanol
C23OH 0.8                                      tricosanol
C24OH 30.3                                    tetracosanol
C25OH  1.9                                     pentacontanol
C26OH 37.3                                    hexacosanol
C27OH   1.5                                    heptacontanol
C28OH 15.3                                    octacosanol
C29OH   0.3                                    nonacosanol 
C30OH   1.1                                    triacontanol
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